Catalyst
Slingshot members are tracking this event:
Update on the U.K.’S Competition and Markets Authority’s Review of Acadia Healthcare’s Acquisition of Priory Group
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ACAD |
|
|
Additional Information
Should the CMA proceed with the Phase 2 assessment, they will continue to investigate whether the Priory acquisition has created a relevant merger situation that has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the U.K. for inpatient behavioral healthcare services. The Phase 2 assessment is expected to take approximately nine months to complete. During this period, the “hold-separate” requirements will remain in place.Acadia will conduct a conference call with institutional investors and analysts today at 10:30 a.m. ET to discuss the CMA’s decision. Additionally, a live broadcast of the conference call will be available at www.acadiahealthcare.comin the “Investors” section of the website. The webcast of the conference call will be available through July 31, 2016.
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 14, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Acquisition